XML 46 R33.htm IDEA: XBRL DOCUMENT

Stockholders’ Deficit (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Stockholders’ Deficit

The following table summarizes the activity in the Company’s various classes of preferred stock included in Stockholders’ Deficit for the years ended December 31, 2022 and 2021:

Schedule of Stockholders’ Deficit

		Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount
		Series H								Series F								Series L								Series M								Series N								Series O								Series P								Total
		Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount
Balance December 31, 2021			10			$	-				1,750,000			$	17,500				250,000			$	2,500				20,810			$	208				5,936			$	59				9,900			$	99				8,545			$	85				2,045,201			$	20,451
Conversion of Series F Preferred Stock into common stock			-				-				(1,750,000	)			(17,500	)			-				-				-				-				-				-								-				-				-				(1,750,000	)			(17,500	)
Issuances of Series P Preferred Stock			-				-				-				-				-				-				-				-				-				-				-				-				1,650				17				1,650				17
Conversion of Series M Preferred Stock into common stock			-				-
Conversions of Series M Preferred Stock into common stock, Shares			-				-
Exchange of Series M Preferred Stock for common stock			-				-
Exchange of Series M Preferred Stock for common stock, Shares			-				-
Conversions of Series N Preferred Stock into common stock			-				-				-				-				-				-				-								(3,036	)			(30	)			-				-				-				-				(3,036	)			(30	)
Conversions of Series O Preferred Stock into common stock			-				-				-				-				-				-				-				-				-				-				(1,215	)			(12	)			-				-				(1,215	)			(12	)
Balance December 31, 2022			10			$	-				-			$	-				250,000			$	2,500				20,810			$	208				2,900			$	29				8,685			$	87				10,195			$	102				292,600			$	2,926

		Series H								Series F								Series L								Series M								Series N								Series O								Series P								Total
		Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount				Shares				Amount
Balance December 31, 2020			10			$	-				1,750,000			$	17,500				250,000			$	2,500				22,000			$	220				29,434			$	294				-			$	-				-			$	-				2,051,444			$	20,514
Beginning balance			10			$	-				1,750,000			$	17,500				250,000			$	2,500				22,000			$	220				29,434			$	294				-			$	-				-			$	-				2,051,444			$	20,514
Issuances of Series O Preferred Stock			-				-				-				-				-				-				-				-				-				-				9,900				99				-				-				9,900				99
Issuance of Series P Preferred Stock			-				-				-				-				-				-				-				-				-				-				-				-				8,545				85				8,545				85
Exchange of Series M Preferred Stock for common stock			-				-				-				-				-				-				(570	)			(6	)			-				-				-				-				-				-				(570	)			(6	)
Conversion of Series M Preferred Stock into common stock			-				-				-				-				-				-				(620	)			(6	)			-				-				-				-				-				-				(620	)			(6	)
Conversions of Series N Preferred Stock into common stock			-				-				-				-				-				-				-				-				(23,498	)			(235	)			-				-				-				-				(23,498	)			(235	)
Balance December 31, 2021			10			$	-				1,750,000			$	17,500				250,000			$	2,500				20,810			$	208				5,936			$	59				9,900			$	99				8,545			$	85				2,045,201			$	20,451
Ending balance			10			$	-				1,750,000			$	17,500				250,000			$	2,500				20,810			$	208				5,936			$	59				9,900			$	99				8,545			$	85				2,045,201			$	20,451

Schedule of Stock Option Activity

Schedule of Stock Option Activity

		Number of options				Weighted- average exercise price				Weighted- average contractual term (years)
Outstanding at December 31, 2020			26			$	2,992,125				5.33
Granted			-
Expired			-
Outstanding at December 31, 2021			26			$	2,992,125				4.33
Granted			-
Expired			-
Outstanding at December 31, 2022			26			$	2,992,125				3.37

Exercisable at December 31, 2022			26			$	2,992,125

Schedule of Stock Option Outstanding and Exercisable

The following table summarizes information with respect to stock options outstanding and exercisable by employees and directors at December 31, 2022:

Options outstanding Options vested and exercisable

Exercise price Number outstanding Weighted average remaining contractual life (years) Weighted average exercise price Aggregate intrinsic value Number vested Weighted average exercise price Aggregate intrinsic value

$ 10,000,000 5 3.25 $ 10,000,000 $ - 5 $ 10,000,000 $ -

$ 5,000,000 5 3.25 $ 5,000,000 - 5 $ 5,000,000 -

$ 269,580 8 3.33 $ 269,580 - 8 $ 269,580 -

$ 80,906 8 3.54 $ 80,906 - 8 $ 80,906 -

26 3.37 $ 2,992,125 $ – 26 $ 2,992,125 $ -

Schedule of Warrants Activity

The following summarizes the information related to the number of shares of common stock issuable under outstanding warrants during the years ended December 31, 2022 and 2021:

Schedule of Warrants Activity

		Number of Shares of Common Stock Issuable for Warrants				Weighted average exercise price
Balance at December 31, 2020			467			$	195,607
Issuance of warrants			4,750				70.00
Increase in number of shares of common stock issuable under warrants during the period as a result of down round provisions			54,798,363				-
Expiration of warrants			(522,922	)			(27.11	)
Balance at December 31, 2021			54,280,658			$	1.43
Issuance of warrants			-				-
Expiration of warrants			(33,601,211	)			(0.9141	)
Increase in number of shares of common stock issuable under warrants during the period as a result of down round provisions			511,312,671,643				-
Balance at December 31, 2022			511,333,351,090			$	0.00009